Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
The Lancet. Oncology
|
March 16, 2020
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 26, 2021
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial
Eleni Gkika, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
Dejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
Cancers
|
November 18, 2020
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial
Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch, et al.
The Lancet. Oncology
|
December 22, 2025
O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial
Anca-Ligia Grosu, Wolfgang A Weber, Erika Graf, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
Simon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Nuklearmedizin. Nuclear Medicine
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 7, 2021
Correction to: Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
The Lancet. Oncology
|
March 16, 2020
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Ursula Nestle, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 26, 2021
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial
Eleni Gkika, Tanja Schimek-Jasch, Stephanie Kremp, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 31, 2020
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
Dejan Kostyszyn, Tobias Fechter, Nico Bartl, et al.
Cancers
|
November 18, 2020
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial
Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch, et al.
The Lancet. Oncology
|
December 22, 2025
O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial
Anca-Ligia Grosu, Wolfgang A Weber, Erika Graf, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
Simon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Nuklearmedizin. Nuclear Medicine
|
July 14, 2021
Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
October 7, 2021
Correction to: Value of PET imaging for radiation therapy
Constantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Page
of 12